Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:38 AM
Ignite Modification Date:
2025-12-26 @ 1:16 AM
NCT ID:
NCT02660034
Group ID:
EG008
Title:
Part B: Dose Expansion Phase - Arm 3
Description:
Participants with mCRPC with either known germline or somatic BRCA1/2 mutations or with documented HRD received tislelizumab 200 mg IV Q3W + pamiparib 40 mg orally twice daily. Chemotherapy-naïve participants must have received prior abiraterone acetate or enzalutamide treatment.
Deaths Number Affected:
9
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
20
Other Number Affected:
13
Other Number At Risk:
20
Study:
NCT02660034
Results Section:
NCT02660034
Adverse Events Module:
NCT02660034